Literature DB >> 34508671

Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa.

C Wendy Spearman1, Mary Afihene2, Omolade Betiku3, Bilal Bobat4, Lina Cunha5, Chris Kassianides6, Leolin Katsidzira7, Hailemichael D Mekonnen8, Ponsiano Ocama9, Olusegun Ojo10, Imran Paruk11, Christian Tzeuton12, Mark W Sonderup13.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease globally and is estimated to affect approximately 25% of the world's population. Data about the prevalence and incidence of NAFLD in Africa are scarce, but the prevalence is estimated to be 13·5% for the general population. This is likely to be an underestimate considering the increasing burden of non-communicable diseases, particularly the rising prevalence of obesity and type 2 diabetes, driven by the overlapping challenges of food insecurity, nutritional transition, and associated increased consumption of calorie-dense foods. Establishing the true prevalence of NAFLD, raising public awareness around the risk factors behind the increase in NAFLD, and proactively addressing all components of metabolic syndrome will be important to combat this silent epidemic, which will have long-term health-care costs and economic consequences for the region.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34508671     DOI: 10.1016/S2468-1253(21)00275-2

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  1 in total

1.  Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores.

Authors:  Yonghui Wu; Xi Yang; Heather L Morris; Matthew J Gurka; Elizabeth A Shenkman; Kenneth Cusi; Fernando Bril; William T Donahoo
Journal:  JMIR Med Inform       Date:  2022-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.